About: A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
Creator	Neyts, Johan Jochmans, Dirk Leyssen, Pieter
source	Elsevier; Medline; PMC
abstract	For antiviral screenings purposes, infection of cell cultures with the virus under study, should ideally result in the induction, within just a few days, of (nearly) complete CPE and allow the calculation of acceptable Z’ factors (>0.5). The human Corona virus NL63 (HCoV-NL63) causes only limited CPE on different cell lines (Schildgen et al., 2006). Following infection of Vero118 cells, virus-induced CPE was too low to allow readout based on classical colorimetric methods (such as the MTS assay), even following prolonged incubation times (>7 days). To develop an antiviral screenings-assay against HCoV-NL63, we explored whether a dead-cell protease substrate could be used instead. The substrate used is a quenched peptide (bis-AAF-R110) that releases a fluorophore upon proteolytic-cleavage by proteases; the latter released from dead cells. Following different rounds of optimization a screening protocol was developed: Vero118 cells in 96-well plate format were infected with HCoV-NL63 (MOI = 0.01; 200 μL cell culture; 2.10(4) cells/mL, IMDM 5% FBS medium). Cultures were subsequently incubated for 5 days at 35 °C after which 20 μL of the peptide solution was added. Fluorescence was quantitated 2 hr after incubation at 37 °C. A roughly 3-fold increase in fluorescence intensity in the infected cultures was observed as compared to the uninfected cultures with a low well-to-well variability. Z’ factors calculated from different experiments were in the range of 0.6–0.8, indicating excellent assay quality. An anti-ACE2 polyclonal antiserum (that prevents coronavirus infection in cell cultures) was used as a positive control and allowed to validate the assay for antiviral screening purposes. In conclusion, in conditions where a viability staining is inadequate to quantitate virus-induced CPE, a novel simple and convenient method that detects cell-death and that is suitable for high-throughput screening purposes can be employed.
has issue date	2012-04-28(xsd:dateTime)
bibo:doi	10.1016/j.jviromet.2012.04.011
bibo:pmid	22575574
has license	no-cc
sha1sum (hex)	452dee76eee0fc72fa4371889697751854c99785
schema:url	https://doi.org/10.1016/j.jviromet.2012.04.011
resource representing a document's title	A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
has PubMed Central identifier	PMC7112866
has PubMed identifier	22575574
schema:publication	J Virol Methods
resource representing a document's body	covid:452dee76eee0fc72fa4371889697751854c99785#body_text
is schema:about of	named entity 'cells' named entity 'roughly' named entity 'fluorescence' named entity 'times' named entity 'antiviral' named entity 'assay' named entity 'antiviral' named entity 'CONCLUSION' named entity 'CALCULATION' named entity 'NOVEL' named entity 'ANTIVIRAL ACTIVITY' named entity 'VIRUSES' named entity 'DEAD' named entity 'IMDM' named entity 'FLUORESCENCE' named entity 'FORMAT' named entity 'NOVEL' named entity 'FOLD INCREASE' named entity 'EXCELLENT' named entity 'CONDITIONS' named entity 'CELL LINES' named entity 'CELLS' named entity 'PROTOCOL' named entity 'ACCEPTABLE' named entity 'FOLLOWING' named entity 'ADDED' named entity 'INCUBATED' named entity 'DIFFERENT' named entity 'SUBSTRATE' named entity 'AAF' named entity 'METHOD' named entity 'EMPLOYED' named entity 'ASSAY' named entity 'STUDY' named entity 'HUMAN' named entity 'WHERE' named entity 'FBS' named entity 'USED' named entity 'PROTEASE' named entity 'SOLUTION' named entity 'METHOD' named entity 'VIRUS' named entity 'FLUORESCENCE INTENSITY' named entity 'CELL' named entity 'INDUCTION' named entity 'TIMES' named entity 'ROUNDS' named entity 'INCUBATION' named entity 'CALCULATED' named entity '0.01' named entity 'RANGE' named entity 'QUALITY' named entity 'INDUCED' named entity 'HCOV-NL63' named entity 'CULTURES' named entity 'METHODS' named entity 'SIMPLE' named entity 'RESULT' named entity 'COULD BE' named entity 'POSITIVE CONTROL' named entity 'RELEASED' named entity 'CORONA' named entity 'INFECTION' named entity 'VARIABILITY' named entity 'QUANTIFY' named entity 'HIGH-THROUGHPUT SCREENING' named entity 'LIMITED' named entity 'LIMITED' named entity 'PROLONGED' named entity 'NL63' named entity 'IS A' named entity '80%' named entity 'READOUT' named entity 'OBSERVED' named entity 'OPTIMIZATION' named entity 'JUST' named entity 'SCREENINGS' named entity 'DEAD-CELL' named entity 'CPE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software